Status:
WITHDRAWN
Treatment With Duloxetine for OCD Patients
Lead Sponsor:
Sheba Medical Center
Conditions:
OCD
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
Testing the efficacy of the SNRI medication Duloxetine for treating OCD patients who did not respond to SSRI
Eligibility Criteria
Inclusion
- OCD as main diagnosis according to DSM-IV
- Age 18 to 65
- Men and women
- YBOCS score is 18 or more, or 12 or more in case of only obsessions
Exclusion
- Patients treated with Duloxetine, currently or in the past
- Patients having comorbid schizophrenia or psychotic disorder or bipolar disorder Patients with substance abuse disorder in the last 6 months Patients who were suicidal or did serious suicide attempt in the last year Pregnant or lactating women, or woman of childbearing potential, which is not using adequate contraception Patients with neurologic disturbance or disorder Patients with serious or imbalanced medical condition Patients with allergic response to SSRI or duloxetine Patients who started new treatment (CBT or pharmacology) in less than 3 months
Key Trial Info
Start Date :
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT00399022
Last Update
January 31 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Chaim Sheba Medical Center
Ramat Gan, Israel, 52621